Accueil Ernstrade Bourse Actualite Stock

plus500


EURONEXT BRUSSELS

Arseus NV is a Belgium-based company that provides products, services and concepts for professionals and institutions active in the healthcare sector in Europe. Arseus is subdivided into four divisions and, among other things, is active in the markets for magisterial preparations for pharmacies, dental products, medical and surgical products and medical IT solutions. The Company distributes medical equipment and consumables in Belgium, Germany, Italy, The Netherlands, Switzerland, France, Spain, Czech Republic and the United Kingdom. Arseus NV is a part of the Omega Pharma Group and has various subsidiaries, including ABC Ducro Dental BV, Arseus Medical BV, Corilus BV, De Collegiale Bereiding BV and Fagron BV. 

http://www.arseus.com


ARSEUS: DISCLOSURE OF ACQUISITION OF TREASURY SHARES
30 December 2014
Waregem (Belgium) / Rotterdam (the Netherlands)[1], 30 December 2014 - Arseus discloses the information with respect to the acquisition of treasury shares required under Article 207 of the Royal Decree of 30 January 2001 implementing the Belgian Company Code.

Arseus today announces that during the period from 17 December 2014 to 29 December 2014, it acquired 59,539 treasury shares on Euronext Brussels.

Acquisition date    Number of shares    Average price    Lowest price    Highest price    Amount
17 December 2014    20,000    € 31.4422    € 31.35    € 31.50    € 628,844
18 December 2014    19,000    € 31.9428    € 31.55    € 32.20    € 606,913
19 December 2014    20,539    € 32.7079    € 32.45    € 33.00    € 671,788
22 December 2014    -    -    -    -    -
23 December 2014    -    -    -    -    -
24 December 2014    -    -    -    -    -
29 December 2014    -    -    -    -    -
The Extraordinary General Meeting held on 12 December 2014 approved the authorisation of the Board of Directors to acquire treasury shares.

Prior to the transactions, Arseus held 517,940 treasury shares. As a result of the acquisition of 59,539 treasury shares, Arseus now holds 577,479 treasury shares, representing 1.84% of the total number of shares outstanding.

Arseus will publish a weekly update every Monday provided that shares were bought back in the preceding week.

In the event of any discrepancy between the English translation and the original Dutch version of this press release, the latter shall prevail.

For further information:

Marieke Palstra

Director Investor Relations

+31 88 33 11 213

marieke.palstra@arseus.com

[1] This press release was sent out by Arseus NV and Arseus BV.

Please open the link below for the press release:



 

Copyright  2017 Ernstrade.com